scispace - formally typeset
C

Christopher M. Dixon

Researcher at New York University

Publications -  22
Citations -  3699

Christopher M. Dixon is an academic researcher from New York University. The author has contributed to research in topics: Magnetic resonance imaging & Finasteride. The author has an hindex of 15, co-authored 20 publications receiving 3500 citations. Previous affiliations of Christopher M. Dixon include San Francisco General Hospital.

Papers
More filters
Journal ArticleDOI

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.

TL;DR: In men with benign prostatic hyperplasia, terazosin was effective therapy, whereas finasteride was not, and the combination of terazOSin and finasterside was no more effective than terazoshin alone.
Journal ArticleDOI

Consensus statement on bladder injuries

TL;DR: The consensus on genitourinary trauma continues this month with the statement on bladder trauma from several internationally recognised experts, which describes blunt, penetrating and iatrogenic injuries and their management, considering paediatric injuries separately.
Journal ArticleDOI

A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia

TL;DR: Considering the lower morbidity, shorter procedure and hospitalization times, and the degree of effectiveness that was achieved even at the low-energy doses used in this study, VLAP appears to be a viable and safe alternative to standard TURP.
Journal ArticleDOI

Renal Reconstruction After Injury

TL;DR: Renal exploration after trauma is safe and in a high percentage of cases reconstruction will be successful, and the success rate was based on early vascular control and reconstructive techniques of "renorrhaphy," partial nephrectomy, vascular repair and coverage with omental pedicle flaps.